Synapse - Christopher Azzoli

Search Within

Christopher G Azzoli

Results (111)

Use of epidermal growth factor receptor/kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: Comparison with clinical guidelines

Journal Article

Girard, N.; Deshpande, C.; Azzoli, C. G.; Rusch, V. W.; Travis, W. D.; Ladanyi, M.; Pao, W.
Chest (2010)

Fulltext@MSK | Save

Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer

Journal Article

De Braganca, K. C.; Janjigian, Y. Y.; Azzoli, C. G.; Kris, M.; Pietanza, M. C.; Nolan, C.; Omuro, A. M.; Holodny, A.; Lassman, A. B.
Journal of Neuro-Oncology (2010)

Fulltext@MSK | Save

Phase II study of induction and adjuvant bevacizumab in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) receiving induction docetaxel and cisplatin

Meeting Abstract

Price, K.; Kris, M. G.; Rusch, V.; Finley, D. J.; Azzoli, C. G.; Downey, R. J.; Bains, M. S.; Miller, V. A.; Rizk, N.; Rizvi, N. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations

Meeting Abstract

Janjigian, Y. Y.; Park, B. J.; Kris, M. G.; Miller, V. A.; Riely, G. J.; Zheng, J.; Dycoco, J. P.; Shen, R.; Azzoli, C. G.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The initial Memorial Sloan-Kettering Cancer Center (MSKCC) experience

Meeting Abstract

Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.; Park, B.; Finley, D.; Azzoli, C.; Kris, M. G.; Rusch, V.; Miller, V.; Riely, G.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Meeting Abstract

Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Phase II trial of dasatinib for patients demonstrating acquired resistance to treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) erlotinib (E) or gefitinib (G)

Meeting Abstract

Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

A prospective study of serial measurements of cell-free DNA in plasma, radiographic response, and overall survival in patients with metastatic non-small cell lung cancer (NSCLC)

Meeting Abstract

Azzoli, C. G.; Johnson, M.; Morita, S.; Motoyama, K.; Subzwari, S.; Hsu, M.; Shen, R. L.; Danenberg, K.; Danenberg, P.; Kris, M. G.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer

Journal Article

Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Patterns of co-expression of ERCC1 and p27 in resected non-small cell lung cancer by immunohistochemistry

Meeting Abstract

Rekhtman, N.; Azzoli, C. G.; Kris, M. G.; Park, B. J.; Zakowski, M. F.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save